OptimizeRx Co. (NASDAQ:OPRX) Receives Average Rating of “Moderate Buy” from Analysts
OptimizeRx Co. (NASDAQ:OPRX – Get Free Report) has been assigned an average recommendation of “Moderate Buy” from the nine ratings firms that are presently covering the firm, MarketBeat Ratings reports. Three investment analysts have rated the stock with a hold rating, five have given a buy rating and one has assigned a strong buy rating […]
OptimizeRx Co. (NASDAQ:OPRX – Get Free Report) has been assigned an average recommendation of “Moderate Buy” from the nine ratings firms that are presently covering the firm, MarketBeat Ratings reports. Three investment analysts have rated the stock with a hold rating, five have given a buy rating and one has assigned a strong buy rating […]
